中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

151 records (took 0.021 seconds)

    45.
    发明专利
    未知

    公开(公告)号：AT383381T

    公开(公告)日：2008-01-15

    申请号：AT06112175

    申请日：2006-04-03

    Applicant: BASF AG

    Inventor： KOLTER KARL ,  ASCHERL HERMANN ,  FUSSNEGGER BERNHARD

    IPC: C08F226/06 ,  A61K9/20 ,  C08F6/12

    Abstract: Purify-hasty, powdered bonding agents comprises a vinyllactampolymer, where the bonding agents exhibits an average particle size of upto 35 mu m and a bulk density of smaller than 0.2 g/ml. Independent claims are included for: (1) use of the bonding agent for production of tablets with high firmness; and (2) the preparation of the bonding agents.

    46.
    发明专利
    未知

    公开(公告)号：AT368452T

    公开(公告)日：2007-08-15

    申请号：AT03711965

    申请日：2003-03-11

    Applicant: BASF AG

    Inventor： KOLTER KARL ,  BODMEIER ROLAND ,  DASHEVSKIY ANDRIY

    IPC: A61K9/50 ,  A61K9/22 ,  A61K9/32

    Abstract: The invention relates to the combination of polyvinyl acetate and water-insoluble, acid-insoluble, or alkali-insoluble polymers used for producing film coatings for forms of administration in which agents are released in a controlled manner, and methods for the production thereof. The controlled-release properties can be specifically adjusted by means of said combinations, resulting in films having excellent mechanical stability and storage stability. In particular, agents are released independent of the pH by means of the inventive forms of administration.

    48.
    发明专利
    未知

    公开(公告)号：DE102005049001A1

    公开(公告)日：2007-04-12

    申请号：DE102005049001

    申请日：2005-10-11

    Applicant: BASF AG

    Inventor： MEYER-BOEHM KATHRIN ,  KOLTER KARL ,  QUADIR ANISUL

    IPC: A61K31/192 ,  A61K9/20

    Abstract: A directly tabletable ibuprofen formulation comprising a) 50-99% by weight of crystalline ibuprofen, b) 1-15% by weight of a finely divided excipient with a surface area of at least 100 m2/g, and c) 0-40% by weight of further excipients, with the proviso that the total amount of components a) to c) corresponds to 100% by weight, where at least 50% of the surface of the ibuprofen crystals are covered with the finely divided excipient.

    49.
    发明专利
    未知

    公开(公告)号：DE102005043172A1

    公开(公告)日：2007-03-15

    申请号：DE102005043172

    申请日：2005-09-09

    Applicant: BASF AG

    Inventor： KOLTER KARL

    IPC: C08J5/00 ,  A01N25/28 ,  A61K8/11 ,  A61K9/48 ,  C08L29/04 ,  C08L51/08 ,  C11D17/00 ,  C11D17/08

    Abstract: A process for producing gelatin-free soft capsule shells based on polyvinyl alcohol-polyether graft copolymers as shell polymers, which comprises heating an aqueous solution comprising at least 45% by weight, based on the total weight of the solution, of a polymer component, where the polymer component consists of a polyvinyl alcohol-polyether graft copolymer or a mixture of polyvinyl alcohol-polyether graft copolymers and polyvinyl alcohol, extruding the solution at a temperature of at least 70° C., and solidifying the resulting film by cooling.

    Use of water-soluble/water-dispersible polymer comprising e.g. ethylenic unsaturated compound, monoethylenic unsaturated amide group compound, cross linker and polyether, for modification of rheologic aqueous composition
    50.
    发明专利
    Use of water-soluble/water-dispersible polymer comprising e.g. ethylenic unsaturated compound, monoethylenic unsaturated amide group compound, cross linker and polyether, for modification of rheologic aqueous composition 未知

    公开(公告)号：DE102005013037A1

    公开(公告)日：2006-09-21

    申请号：DE102005013037

    申请日：2005-03-18

    Applicant: BASF AG

    Inventor： HOESSEL PETER ,  MATHAUER KLEMENS ,  WOOD CLAUDIA ,  LAUBENDER MATTHIAS ,  JAHNEL WOLFGANG ,  GARCIA CASTRO IVETTE ,  WENDEL VOLKER ,  KOLTER KARL

    IPC: C08F283/06 ,  A61K8/81 ,  A61K8/86 ,  A61Q5/06 ,  C08F2/44 ,  C08F8/00 ,  C08F220/00 ,  C08F226/00

    Abstract: Use of water-soluble or water-dispersible polymer by polymerization, comprising at least one alpha ,beta - ethylenic unsaturated compound, at least one of different monoethylenic unsaturated amide group containing compound, a cross linker, at least one monoethylenic unsaturated compound containing at least one group of 5-30C alkyl substituted group, 5-30C alkenyl, 5-8C cycloalkyl, aryl, aryl alkyl and hetaryl, and/or a reactive precursor, 0-30 wt.% of further different monoethylenic unsaturated compound and a polyether containing compound, for modification of the rheologic aqueous composition. Use of water-soluble or water-dispersible polymer by polymerization, comprising 99.99-10 wt.% of at least one alpha ,beta - ethylenic unsaturated compound with at least one cationogenic and/or cationic group per molecule, 0-90 wt.% of at least one of different monoethylenic unsaturated amide group containing compound, 0.01-5 wt.% of cross linker, 0-15 wt.% of at least one monoethylenic unsaturated compound containing at least one group of 5-30C alkyl substituted group, 5-30C alkenyl, 5-8C cycloalkyl, aryl, aryl alkyl and hetaryl, and/or a reactive precursor, 0-30 wt.% of further different monoethylenic unsaturated compound and 0-70 wt.% of a polyether containing compound, where the polymerization is carried out in the presence of less than 69 wt.% of cyclohexane and less than 12 wt.% of water, and the absence of carbon dioxide for modification of the rheologic aqueous composition. Independent claims are included for: (1) a water-soluble or water-dispersible polymer; and (2) a cosmetic or pharmaceutical agent comprising the water-soluble or water-dispersible polymer.

Patent Agency Ranking